LAVA Therapeutics (LVTX) Short Interest Ratio & Short Volume

$2.07

-0.04 (-1.90%)

(As of 07/26/2024 ET)

Compare

LAVA Therapeutics Short Interest Data

Current Short Interest: 52,900 shares
Previous Short Interest: 75,800 shares
Change Vs. Previous Month: -30.21%
Dollar Volume Sold Short: $95,220.00
Short Interest Ratio: 0.7 Days to Cover
Last Record Date: July 15, 2024

Outstanding Shares: 25,350,000 shares
Float Size: 14,120,000 shares
Short Percent of Float: 0.37%
Today's Trading Volume: 21,913 shares
Average Trading Volume: 844,343 shares
Today's Volume Vs. Average: 3%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling LAVA Therapeutics ?

Sign up to receive the latest short interest report for LAVA Therapeutics and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

LVTX Short Interest Over Time

LVTX Days to Cover Over Time

LVTX Percentage of Float Shorted Over Time

Ad Stansberry Research

Get out of cash before the Fed's next meeting

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview

LAVA Therapeutics Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2024	52,900 shares	$95,220.00	-30.2%	0.4%	0.7	$1.80
6/30/2024	75,800 shares	$136,440.00	-5.5%	0.5%	0.8	$1.80
6/15/2024	80,200 shares	$187,668.00	-4.8%	0.6%	0.6	$2.34
5/31/2024	84,200 shares	$190,292.00	-29.0%	0.6%	0.4	$2.26
5/15/2024	118,500 shares	$335,355.00	-2.3%	0.8%	0.1	$2.83
4/30/2024	121,300 shares	$350,557.00	-37.4%	0.9%	0.1	$2.89
Get the Latest News and Ratings for LVTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
4/15/2024	193,800 shares	$567,834.00	-8.4%	1.4%	0.1	$2.93
3/31/2024	211,600 shares	$704,628.00	-34.3%	1.5%	0.1	$3.33
3/15/2024	322,100 shares	$950,195.00	+476.2%	2.3%	0.2	$2.95
2/29/2024	55,900 shares	$186,147.00	+448.0%	0.5%	0	$3.33
2/15/2024	10,200 shares	$20,604.00	-88.4%	0.1%	0	$2.02
1/31/2024	87,700 shares	$146,459.00	+853.3%	0.7%	0.1	$1.67
1/15/2024	9,200 shares	$15,364.00	+15.0%	0.1%	0.3	$1.67
12/31/2023	8,000 shares	$12,640.00	-27.3%	0.1%	0.2	$1.58
12/15/2023	11,000 shares	$17,160.00	-9.8%	0.1%	0.4	$1.56
11/30/2023	12,200 shares	$18,492.76	-28.7%	0.1%	0.4	$1.52
11/15/2023	17,100 shares	$25,480.71	-21.6%	0.1%	0.6	$1.49
10/31/2023	21,800 shares	$25,942.00	-25.3%	0.2%	0.7	$1.19
10/15/2023	29,200 shares	$40,588.00	-20.4%	0.3%	1.4	$1.39
9/30/2023	36,700 shares	$53,949.00	-3.2%	0.3%	1.4	$1.47
9/15/2023	37,900 shares	$64,759.73	-15.0%	0.3%	1.1	$1.71
8/31/2023	44,600 shares	$78,942.00	+34.7%	0.4%	0.7	$1.77
8/15/2023	33,100 shares	$59,580.00	-32.0%	0.3%	0.1	$1.80
7/31/2023	48,700 shares	$91,556.00	-45.2%	0.4%	0.1	$1.88
7/15/2023	88,900 shares	$176,022.00	+95.4%	0.8%	0.1	$1.98
6/30/2023	45,500 shares	$92,365.00	-50.7%	0.5%	0.1	$2.03
6/15/2023	92,300 shares	$180,908.00	+709.7%	0.9%	0.1	$1.96
5/31/2023	11,400 shares	$21,660.00	-46.2%	0.1%	0	$1.90
5/15/2023	21,200 shares	$40,280.00	+50.4%	0.2%	0.4	$1.90
4/30/2023	14,100 shares	$21,291.00	+95.8%	0.2%	0.2	$1.51
4/15/2023	7,200 shares	$12,816.00	-30.1%	0.1%	0.1	$1.78
3/31/2023	10,300 shares	$17,098.00	-40.1%	0.1%	0.2	$1.66
3/15/2023	17,200 shares	$29,584.00	+177.4%	0.2%	0.3	$1.72
2/28/2023	6,200 shares	$13,888.00	+40.9%	0.1%	0.1	$2.24
2/15/2023	4,400 shares	$14,872.00	-17.0%	0.0%	0.1	$3.38
1/31/2023	5,300 shares	$19,292.00	+35.9%	0.0%	0.2	$3.64
1/15/2023	3,900 shares	$15,015.00	-38.1%	0.0%	0.1	$3.85
12/30/2022	6,300 shares	$22,050.00	+34.0%	0.0%	0.1	$3.50
12/15/2022	4,700 shares	$18,142.00	-78.3%	0.0%	0	$3.86
11/30/2022	21,700 shares	$119,567.00	+130.9%	0.1%	0	$5.51
Get out of cash before the Fed's next meeting (Ad) "How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains." Click here now to watch this exclusive interview
11/15/2022	9,400 shares	$50,196.00	No Change	0.0%	0	$5.34
10/31/2022	9,400 shares	$40,702.00	+213.3%	0.0%	0	$4.33
10/15/2022	3,000 shares	$11,880.00	-98.1%	0.0%	0	$3.96
9/30/2022	158,800 shares	$725,716.00	+14,336.4%	1.7%	0.2	$4.57
9/15/2022	1,100 shares	$2,574.00	-31.3%	0.0%	0	$2.34
8/31/2022	1,600 shares	$4,080.00	-36.0%	0.0%	0.3	$2.55
8/15/2022	2,500 shares	$6,275.00	-30.6%	0.0%	0.3	$2.51
7/31/2022	3,600 shares	$9,360.00	+71.4%	0.0%	0.4	$2.60
7/15/2022	2,100 shares	$5,544.00	+2,000.0%	0.0%	0.3	$2.64
6/30/2022	100 shares	$295.00	-85.7%	N/A	0	$2.95
6/15/2022	700 shares	$1,995.00	-30.0%	0.0%	0.1	$2.85
5/31/2022	1,000 shares	$3,000.00	-58.3%	0.0%	0.1	$3.00
5/15/2022	2,400 shares	$9,528.00	+200.0%	0.0%	0.3	$3.97
4/30/2022	800 shares	$3,256.00	+14.3%	0.0%	0.1	$4.07
4/15/2022	700 shares	$2,961.00	-41.7%	0.0%	0.1	$4.23
3/31/2022	1,200 shares	$5,280.00	+20.0%	0.0%	0.1	$4.40
3/15/2022	1,000 shares	$4,360.00	+11.1%	0.0%	0.1	$4.36
2/28/2022	900 shares	$4,122.00	-66.7%	0.0%	0	$4.58
2/15/2022	2,700 shares	$13,527.00	-55.0%	0.0%	0.1	$5.01
1/31/2022	6,000 shares	$33,120.00	-3.2%	0.1%	0.3	$5.52
1/15/2022	6,200 shares	$30,938.00	-55.1%	0.1%	0.3	$4.99
12/31/2021	13,800 shares	$75,900.00	-9.8%	0.2%	0.4	$5.50
12/15/2021	15,300 shares	$78,030.00	-58.8%	0.2%	0.4	$5.10
11/30/2021	37,100 shares	$257,474.00	-28.2%	0.4%	0.9	$6.94
11/15/2021	51,700 shares	$362,934.00	-22.4%	0.6%	1.3	$7.02
10/29/2021	66,600 shares	$507,492.00	-29.6%	0.7%	1.4	$7.62
10/15/2021	94,600 shares	$674,498.00	+26.8%	1.0%	0.6	$7.13
9/30/2021	74,600 shares	$441,632.00	+1.2%	0.8%	0.5	$5.92
9/15/2021	73,700 shares	$467,258.00	+18.1%	0.8%	0.5	$6.34
8/31/2021	62,400 shares	$408,720.00	+2.1%	0.7%	0.5	$6.55
8/13/2021	61,100 shares	$348,881.00	No Change	0.7%	0.5	$5.71

LVTX Short Interest - Frequently Asked Questions

What is LAVA Therapeutics' current short interest?: Short interest is the volume of LAVA Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 52,900 shares of LVTX short. 0.37% of LAVA Therapeutics' shares are currently sold short. Learn More on LAVA Therapeutics' current short interest.
What is a good short interest ratio for LAVA Therapeutics?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LVTX shares currently have a short interest ratio of 1.0. Learn More on LAVA Therapeutics's short interest ratio.
What is a good short interest percentage for LAVA Therapeutics?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.37% of LAVA Therapeutics' floating shares are currently sold short.
Is LAVA Therapeutics' short interest increasing or decreasing?: LAVA Therapeutics saw a decline in short interest in July. As of July 15th, there was short interest totaling 52,900 shares, a decline of 30.2% from the previous total of 75,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is LAVA Therapeutics' float size?: LAVA Therapeutics currently has issued a total of 25,350,000 shares. Some of LAVA Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LAVA Therapeutics currently has a public float of 14,120,000 shares.

How does LAVA Therapeutics' short interest compare to its competitors?: 0.37% of LAVA Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to LAVA Therapeutics: Grifols, S.A. (3.15%), Mainz Biomed (4.79%), NLS Pharmaceutics Ltd. (1.91%), Pharvaris (0.65%), Procaps Group S.A. (0.03%), Qilian International Holding Group Limited (2.48%), Adicet Bio, Inc. (6.50%), Shattuck Labs, Inc. (9.13%), Editas Medicine, Inc. (19.20%), Eli Lilly and Company (0.74%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.
What does it mean to sell short LAVA Therapeutics stock?: Short selling LVTX is an investing strategy that aims to generate trading profit from LAVA Therapeutics as its price is falling. LVTX shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against LAVA Therapeutics?: A short squeeze for LAVA Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LVTX, which in turn drives the price of the stock up even further.
How often is LAVA Therapeutics' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LVTX, twice per month. The most recent reporting period available is July, 15 2024.